Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.
Liam SmythRena BucksteinNancy M PennellRashmi WeerasingheMatthew C CheungKevin ImrieDavid SpanerEugenia PiliotisLisa ChodirkerMarciano ReisZeina GhorabLiying ZhangViolet BoudreauAngela MilikenNeil BerinsteinPublished in: British journal of haematology (2018)